Sunshine Biopharma Enters into Research Deal to Accelerate Development of Anticancer Compound

shot by IP News Shots / 7:35 pm on 19 November, 2020

A research collaboration agreement has been signed by Sunshine Biopharma Inc. with a Montreal-based partner. The research will be focussed on the advancement of Sunshine’s anticancer compound Adva-27a. The partner in the agreement will work on carrying out mice studies to prepare for the entry of the compound in clinical trials.

Read More at: https://www.biospace.com/article/releases/sunshine-biopharma-signs-an-agreement-with-a-montreal-based-company-to-advance-the-development-of-adva-27a-anticancer-compound/

Industry: Pharmaceuticals | Type of IP: Deals - Other Collaborations